___

• Edraki, N., Mehdipour, A. R., Khoshneviszadeh, M., Ramin, M.; Dihydropyridines: Evaluation of Their Current and Future Pharmacological Applications, Drug Discov. To- day, 14(21-22), 1058 (2009).
• Şafak, C., Şimşek, R.; Fused 1,4-Dihydropyridines as Potential Calcium Modulatory Compounds, Mini Rev. Med. Chem., 6, 747 ( 2006).
• Peri, R., Padmanabhan, S., Rutledge, A., Singh, S., Triggle, D.J.; Permanently Charged Chiral 1,4-Dihydropyridines: Molecular Probes of L-Type Calcium Channels. Synthesis and Pharmacological Characterization of Methyl (ω-Trimethylalkylammonium) 1,4-Di- hydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5- pyridinedicarboxylate Iodide, Calcium Channel Antagonists, J. Med. Chem, 43(15), 2906 ( 2000).
• Coburn, R. A., Wierzba, M., Suto, M. J., Solo, A. J., Triggle, A. M., Triggle, D.J.; 1,4-Di- hydropyridine Antagonist Activities at the Calcium Channel: A Quantitative Structure- Activity Relationship Approach, J. Med. Chem., 31(11), 2103 (1988).
• Wojewodzka, M., Gradzka, I., Buraczewska, I., Brzoska, K., Sochanowicz, B., Goncha- rov, R., et al.; Dihydropyridines Decrease X-ray-induced DNA Base Damage in Mam- malian Cells, Mutat. Res., 671(1-2), 45 (2009).
• Mehdipour, A. R., Javidnia, K., Hemmateenejad, B., Amirghofran, Z., Miri, R.; Dihy- dropyridine Derivatives to Overcome Atypical Multidrug Resistance: Design, Synthesis, QSAR Studies, and Evaluation of Their Cytotoxic and Pharmacological Activities, Chem. Biol. Drug Res., 70(4), 337 (2007).
• Samzadeh-Kermani, A., Shafaroodi, H., Miri, R., Mirkhani, H., Vosooghi, M., Shafiee, A.; Lipophilic 2-(4-chlorophenyl)-4-thiazolyl-1,4-dihydropyridines: Synthesis, Calcium Channel Antagonist Activity, and Protection Against Pentylenetetrazole-induced Seizu- re, Med. Chem. Res., 18, 112 (2009).
• Sirisha, K., Achaiah, G., Reddy, V.M.; Facile Synthesis and Antibacterial, Antitubercu- lar, and Anticancer Activities of Novel 1,4-Dihydropyridines, Arch. Pharm. Chem. Life Sci., 343, 342 (2010).
• Sirisha, K., Bikshapathi, D., Achaiah, G., Reddy, V.M.; Synthesis, Antibacterial and Antimycobacterial Activities of Some New 4-Aryl/heteroaryl-2,6-dimethyl-3,5-bis-N- (aryl)-carbamoyl-1,4-dihydropyridines, Eur. J. Med. Chem., 46, 1564 (2011).
• Desai, B., Sureja, D., Naliapara, Y., Shah, A., Saxena, A.K.; Synthesis and QSAR Stud- ies of 4-Substituted phenyl-2,6-dimethyl-3, 5-bis-N-(substituted phenyl)carbamoyl- 1,4-dihydropyridines as Potential Antitubercular Agents, Bioorg. Med. Chem., 9(8), 1993 (2001).
• Kumar, R. S., Idhayadhulla, A., Abdul Nasser, A.J., Selvin, J.; Synthesis and Antimi- crobial Activity of a New Series of 1,4-Dihydropyridine Derivatives, J. Serb. Chem. Soc., 76(1), 1 (2011).
• Pattan, S. R., Butle, S.R. Bhat, A.R., Purohit, S.S.; Synthesis & Evaluation of Some 1,4-Dihydropyridine Derivatives as Anti-microbial Agents, Indian J. Heterocyc. Chem., 14(1), 79 (2004).
• Mithlesh, P., Pawan, K., Kant, R., Shukla, S.K., Ojha, K.G.; Rapid Synthesis and Bio- logical Evaluation of 1, 4-Dihydropyridine Derivatives Containing A Benzothiazolyl Moi- ety, Cent. Eur. J. Chem., 8(1), 163 (2010).
• Şimşek, R., Gündüz, M.G., Sırmagül, B., Şafak, C., Erol, K, Linden, A.; 4-Difluoro- substituted phenyl-5-oxohexahydroquinoline Derivatives and Their Effects on Calcium Channels, Arzneim. Forsch. Drug Res., 56(7), 527 (2006).
• Clinical and Laboratory Standards Institute, Methods for Dilution Antimicrobial Sus- ceptibility Tests for Bacteria That Grow Aerobically, Approved Standard 8th ed., M 07- A8, 2008.
• Clinical and Laboratory Standards Institute, Reference Method for Broth Dilution An- tifungal Susceptibility Testing of Yeasts: Approved Standard 3rd ed., M 27-A3, 2008.